Last reviewed · How we verify
NCT05690243: MIND-MCI
Minds Navigating the Diagnosis of Mild Cognitive Impairment
NA trial testing Group psychotherapy delivered via video telehealth in Cognitive Dysfunction in 160 participants. Status unknown.
31 July 2025
Quick facts
| Lead sponsor | Tuscaloosa Research & Education Advancement Corporation |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 160 |
| Start date | 1 October 2023 |
| Primary completion | 31 July 2025 |
| Estimated completion | 30 September 2025 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Group psychotherapy delivered via video telehealth
Conditions studied
- Cognitive Dysfunction — all drugs for Cognitive Dysfunction →
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Sponsor
Tuscaloosa Research & Education Advancement Corporation
Who can join
60 and older, any sex, with Cognitive Dysfunction or Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to find out if a 9 week group therapy using video from home will help veterans with Mild Cognitive Impairment (MCI). The main questions it aims to answer are: * is the video therapy user-friendly for veterans? * does it improve veterans well-being and quality-of-life? Veterans will be asked to attend nine 1 hour small group video sessions and will complete questionnaires before and after the sessions. Researchers will compare the group of veterans that starts the video sessions right away with a group that waits before starting the video sessions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05690243
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Dysfunction
Currently open trials in the same condition.
- NCT07526740 — Brain Stimulation and Cognitive Training for MCI · NA · recruiting
- NCT07517237 — taVNS + CCT for Neurocognitive Rehab · NA · recruiting
- NCT07171450 — Cognitive Remediation · NA · recruiting
- NCT07418008 — The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) · recruiting
- NCT07394504 — Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy · NA · recruiting
Other Tuscaloosa Research & Education Advancement Corporation trials
Trials by the same sponsor.
- NCT00659230 — Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans · Phase 2 · completed
- NCT01394081 — Alabama Veterans Rural Health Initiative · NA · completed
- NCT00315900 — Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia · Phase 3 · terminated
- NCT00451542 — Divalproex vs. Lamotrigine for Bipolar Disorder · terminated
- NCT00233467 — Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05690243 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tuscaloosa Research & Education Advancement Corporation
- Last refreshed: 24 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05690243.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing